The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)

Safety, pharmacokinetics, and efficacy of RC48-ADC in a phase I study in patients with HER2-overexpression advanced solid cancer.

Jifang  Gong

No Relationships to Disclose

Jianmin  Fang

Employment - RemeGen; RemeGen; RemeGen; RemeGen; RemeGen (I); RemeGen (I); RemeGen (I); RemeGen (I)

Leadership - RemeGen; RemeGen; RemeGen; RemeGen

Stock and Other Ownership Interests  - RemeGen; RemeGen; RemeGen; RemeGen

Research Funding - RemeGen; RemeGen; RemeGen; RemeGen

Patents, Royalties, Other Intellectual Property - RemeGen; RemeGen; RemeGen; RemeGen

Lin  Shen

No Relationships to Disclose